Intracellular calcium

Modulation of intracellular Ca ion concentration is a universal mechanism by which extracellular signals are transduced into an intracellular response⁽Reference Berridge, Lipp and Bootman¹³⁾. Ca levels inside the cell are controlled by both ion influx through channels in the plasma membrane and by release from intracellular stores, and Ca channels in plasma and organelle membranes open in response to extracellular signals in a spatial and temporally specific pattern to cause both local and global increases in intracellular ion concentration⁽Reference Carafoli, Santella, Branca and Brini¹⁴⁾. Intracellular Ca stores in the cell include (1) the endoplasmic reticulum⁽Reference Meldolesi and Pozzan¹⁵⁾, (2) the mitochondria⁽Reference Pozzan, Magalhaes and Rizzuto^16–Reference Collins, Berridge, Lipp and Bootman¹⁸⁾, (3) the nuclear envelope⁽Reference Malviya, Rogue and Vincendon^19–Reference Gerasimenko, Gerasimenko, Tepikin and Petersen²¹⁾, (4) the Golgi apparatus⁽Reference Pinton, Pozzan and Rizzuto²²⁾, (5) secretory granules⁽Reference Yoo²³⁾ and (6) endosomes⁽Reference Gerasimenko, Tepikin, Petersen and Gerasimenko²⁴⁾. There are two other intracellular Ca mobilising molecules in addition to cADPR: nicotinic acid adenine dinucleotide phosphate (NAADP), which is formed from phosphorylated NAD⁽Reference Lee and Aarhus²⁵⁾, and d-myo-inositol 1,4,5-triphosphate (IP₃)⁽Reference Streb, Irvine, Berridge and Schulz²⁶⁾. A summary of the characteristics of IP₃, cADPR and NAADP is presented in Table 1⁽Reference Lee, Walseth, Bratt, Hayes and Clapper^9, Reference Lee and Aarhus^25, Reference Mikoshiba, Furuichi and Miyawaki^27–Reference Aarhus, Graeff, Dickey, Walseth and Lee⁴⁴⁾. Multiplicity of Ca signalling pathways may serve several functions, including redundancy to ensure that Ca signalling occurs and variation in the spatial and temporal Ca response⁽Reference da Silva and Guse⁴⁵⁾. Other compounds such as lysophosphatidic acid⁽Reference Melendez and Allen⁴⁶⁾, sphingosine 1-phosphate⁽Reference Young and Nahorski⁴⁷⁾ and ADP-ribose⁽Reference Lee⁴⁸⁾ are also involved in intracellular Ca mobilisation, although these do not necessarily function as second messengers.

Table 1

Characteristics of inositol 1,4,5-triphosphate (IP₃), cyclic adenosine diphosphate ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP)

ER, endoplasmic reticulum; SR, sarcoplasmic reticulum; IP₃R, IP₃ receptor; RyR, ryanodine receptor; NAADPR, NAADP receptor; CICR, Ca-induced Ca release.

Ca signalling plays a crucial role in regulating many neuronal processes. As reviewed by Berridge⁽Reference Berridge⁴⁹⁾, N- and P/Q-type voltage-activated channels are localised in synaptic terminals, where they regulate neurotransmitter release by generating a local Ca transient which activates synaptotagmin and triggers exocytosis. L-type voltage-activated channels are found on the cell body and proximal dendrites and regulate gene transcription. Synaptic plasticity is thought to be mediated by Ca entry through both voltage- and receptor-operated channels, and by release from IP₃ receptors and ryanodine receptors (RyR). As will be discussed later, modulation of intracellular Ca is required for both long-term potentiation (LTP) and long-term depression (LTD), cellular mechanisms which are thought to contribute to learning and memory⁽Reference Franks and Sejnowski⁵⁰⁾. Similar to neurons, astrocytes also regulate intracellular function through generation of Ca signals; as well, they control the function of neighbouring neurons through global Ca transients⁽Reference Scemes⁵¹⁾.

Cyclic adenosine diphosphate ribose

cADPR has been found to mobilise intracellular Ca in numerous cell types, including protozoa, and those of plants, animals and man⁽Reference Guse⁵²⁾. cADPR mobilises Ca ions via Ca-induced Ca release, whereby the Ca²⁺-releasing mechanism is sensitised by the addition of Ca²⁺⁽Reference Galione, Lee and Busa⁵³⁾. cADPR synthesis is stimulated by cGMP⁽Reference Galione, White, Willmott, Turner, Potter and Watson⁵⁴⁾. cADPR also activates extracellular Ca influx⁽Reference Guse, Berg, da Silva, Potter and Mayr^55, Reference Partida-Sánchez, Cockayne and Monard⁵⁶⁾. The function of cADPR has been investigated in a wide range of cell types, and a summary of the intracellular effects of cADPR is presented in Table 2 (summarised in part from Guse⁽Reference Guse⁵²⁾). Table 2⁽Reference Gerasimenko, Gerasimenko, Tepikin and Petersen^21, Reference Partida-Sánchez, Cockayne and Monard^56–Reference Yusufi, Cheng, Thompson, Dousa, Warner, Walker and Grande⁹²⁾ shows that cADPR administration brings about a variety of changes in neurons, including neurotransmitter release.

Table 2

Intracellular effects of cyclic adenosine diphosphate ribose

SR, sarcoplasmic reticulum; CICR, Ca-induced Ca release.

The principal target of cADPR is the RyR⁽Reference Galione, Lee and Busa⁵³⁾. cADPR might bind directly to the RyR, or an additional binding protein might be required. The binding protein FKPB 12·6 has been found to act as a cADPR-binding protein in several cell types, including pancreatic islets⁽Reference Noguchi, Takasawa, Nata, Tohgo, Kato, Ikehata, Yonekura and Okamoto⁸⁴⁾ and smooth muscle cells⁽Reference Tang, Chen, Zou, Campbell and Li^66, Reference Li, Tang, Valdivia, Zou and Campbell⁶⁴⁾. Binding of cADPR to a target protein might cause release of the protein from the RyR, allowing opening of the RyR Ca channel⁽Reference Guse⁹³⁾. The Ca-binding protein calmodulin is involved in cADPR-mediated Ca release from the RyR⁽Reference Lee, Aarhus, Graeff, Gurnack and Walseth⁹⁴⁾, and tyrosine phosphorylation of the RyR increases cADPR-mediated Ca release⁽Reference Guse, Tsygankov, Weber and Mayr⁹⁵⁾. RyR, which are primarily found on the endoplasmic reticulum/sarcoplasmic reticulum (ER/SR) membrane, are not evenly distributed throughout the cell and distribution patterns vary across cell types⁽Reference Guse⁹³⁾. In addition to the ER/SR, RyR are also found in mitochondria⁽Reference Beutner, Sharma, Giovannucci, Yule and Sheu⁹⁶⁾ and in the nuclear envelope⁽Reference Khoo and Chang^97, Reference Adebanjo, Anandatheerthavarada and Koval⁹⁸⁾. Of the three RyR isoforms, cADPR has been shown to bind to type II and III⁽Reference Galione, White, Willmott, Turner, Potter and Watson^54, Reference Schwarzmann, Kunerth, Weber, Mayr and Guse⁹⁹⁾. An alternative mechanism has been proposed for cADPR whereby cADPR promotes refilling of depleted Ca stores rather than acting on RyR to induce Ca release⁽Reference Lukyanenko, Gyorke, Wiesner and Gyorke¹⁰⁰⁾. The precise target of cADPR and any associated binding proteins is still not well understood.

CD38

The synthesis of cADPR is catalysed by the ADP-ribosyl cyclase family of enzymes. These include: CD38, a type II ectoenzyme that is also expressed intracellularly⁽Reference Lee, Graeff and Walseth³⁹⁾; BST-1, also known as CD157, a bone marrow stromal cell-surface antigen⁽Reference Itoh, Ishihara, Tomizawa, Tanaka, Kobune, Ishikawa, Kaisho and Hirano¹⁰¹⁾; a soluble cyclase characterised from the ovotestes of the Aplysia mollusk and of dogs⁽Reference Lee, Graeff and Walseth³⁹⁾; a membrane-bound cyclase from canine spleen⁽Reference Kim, Jacobson and Jacobson¹⁰²⁾; a membrane-bound cyclase from mouse brain⁽Reference Ceni, Pochon, Villaz, Muller-Steffner, Schuber, Baratier, De Waard, Ronjat and Moutin¹⁰³⁾. The ADP-ribosyl cyclase enzymes are multifunctional, catalysing three reactions: (1) cyclisation of NAD⁺ (ADP-ribosyl cyclase activity), (2) hydrolysis of cADPR to ADP-ribose (cADPR hydrolase activity) and (3) hydrolysis of NAD⁺ to ADP-ribose (NAD⁺ hydrolase activity)⁽Reference Lee, Graeff and Walseth³⁹⁾. ADP-ribosyl cyclase enzymes also catalyse the exchange of nicotinamide and nicotinic acid to form NAADP⁽Reference Lee, Graeff and Walseth³⁹⁾.

CD38 is the most highly investigated ADP-ribosyl cyclase enzyme, and for years it has generated discussion related to its ‘topological paradox’. This paradox questions how CD38, which has an active site facing the exterior of the cell, can regulate the synthesis of an intracellular signalling molecule⁽Reference De Flora, Guida, Franco and Zocchi¹⁰⁴⁾. BST-1 (CD157) shows a similar extracellular location⁽Reference Itoh, Ishihara, Tomizawa, Tanaka, Kobune, Ishikawa, Kaisho and Hirano¹⁰¹⁾. As explanation, it has been demonstrated that cells possess connexin 43 hemichannels that allow passage of NAD⁺ from the inside to the outside of the cell⁽Reference Bruzzone, Guida, Zocchi, Franco and De Flora¹⁰⁵⁾. There is also bidirectional transport of cADPR through CD38 itself⁽Reference Franco, Guida, Bruzzone, Zocchi, Usai and De Flora¹⁰⁶⁾. Intracellular NAD⁺, which is found at micromolar concentrations (as compared with nanomolar concentrations extracellularly), can move down its concentration gradient through the connexon 43 channels to the ectocellular active site of CD38. CD38 can then catalyse the formation of cADPR, which passes through the central channel formed by the homodimeric structure of the protein⁽Reference De Flora, Zocchi, Guida, Franco and Bruzzone¹⁰⁷⁾. Alternatively, cADPR can pass into the cell through nucleoside transporters⁽Reference Guida, Bruzzone, Sturla, Franco, Zocchi and De Flora¹⁰⁸⁾. The process of nucleotide transport can occur via an autocrine mechanism, with the NAD⁺ and cADPR affecting the emitting cell, or a paracrine mechanism, with the nucleotides affecting cells in the vicinity of the emitting cell⁽Reference De Flora, Zocchi, Guida, Franco and Bruzzone¹⁰⁷⁾. For example, increasing extracellular cADPR increases proliferation in human haematopoietic cells⁽Reference Podestà, Zocchi and Pitto¹⁰⁹⁾ and in 3T3 fibroblasts⁽Reference Franco, Zocchi, Usai, Guida, Bruzzone, Costa and De Flora¹¹⁰⁾. In the brain, astrocytes respond to extracellular cADPR by increasing intracellular Ca levels which in turn increase neurotransmitter release⁽Reference Verderio, Bruzzone, Zocchi, Fedele, Schenk, De Flora and Matteoli¹¹¹⁾, while in bovine tracheal smooth muscle cells, extracellular cADPR increases intracellular Ca and potentiates acetylcholine-induced contraction⁽Reference Franco, Bruzzone, Song, Guida, Zocchi, Walseth, Crimi, Usai, De Flora and Brusasco¹¹²⁾. However, CD38 is also localised to intracellular membranes, including the nucleus and the endoplasmic reticulum⁽Reference Khoo and Chang^97, Reference Adebanjo, Anandatheerthavarada and Koval^98, Reference Sun, Adebanjo and Koval^113–Reference Ceni, Pochon and Brun¹¹⁵⁾, which suggests that this enzyme also has an intracellular site of action. And, as previously mentioned, other soluble and membrane-bound ADP-ribosyl cyclase enzymes have been identified, so there is evidence for both intracellular and extracellular cyclases, although much remains to be understood about their precise roles in cADPR synthesis. Both CD38-⁽Reference Ceni, Pochon and Brun¹¹⁵⁾ and non-CD38⁽Reference Ceni, Muller-Steffner, Lund, Pochon, Schweitzer, De Waard, Schuber, Villaz and Moutin^43, Reference Ceni, Pochon, Villaz, Muller-Steffner, Schuber, Baratier, De Waard, Ronjat and Moutin¹⁰³⁾-dependent ADP-ribosyl cyclase activity has been found in the brain. Distribution of CD38 in both rat⁽Reference Yamada, Mizuguchi, Otsuka, Ikeda and Takahashi¹¹⁶⁾ and human⁽Reference Mizuguchi, Otsuka, Sato, Ishii, Kon, Yamada, Nishina, Katada and Ikeda¹¹⁷⁾ brain is widespread.

Cyclic adenosine diphosphate ribose and hippocampal synaptic plasticity

LTP and LTD, which are long-lasting increases and decreases (respectively) in synaptic strength, are used experimentally to model learning and memory⁽Reference Malenka and Bear¹¹⁸⁾. While there are various forms of LTD and LTP that differ in many respects, in all cases there is an increase in intracellular Ca levels. Induction of LTP requires a substantial rise in intracellular Ca, while a more moderate rise in intracellular Ca results in induction of LTD⁽Reference Franks and Sejnowski⁵⁰⁾. At least in N-methyl-d-aspartate acid receptor (NMDAR)-dependent forms, the signal cascade generated following LTP induction involves activation of Ca-dependent protein kinases such as Ca calmodulin kinase II⁽Reference Malinow, Schulman and Tsien^119, Reference Silva, Wang, Paylor, Wehner, Stevens and Tonegawa¹²⁰⁾, while that generated following LTD induction involves activation of Ca-dependent phosphatases such as calcineurin⁽Reference Mulkey, Endo, Shenolikar and Malenka^121, Reference Mulkey, Herron and Malenka¹²²⁾. With respect to Ca-release channels, RyR are particularly concentrated in the dendritic spines of the hippocampus, in contrast to IP₃ receptors, which are concentrated in the dendritic shafts⁽Reference Sharp, McPherson, Dawson, Aoki, Campbell and Snyder⁴¹⁾. The Ca in dendritic spines has been proposed as being especially important in synaptic plasticity⁽Reference Sabatini, Oertner and Svoboda¹²³⁾, so Ca released from RyR might be particularly essential for modulating hippocampal synaptic function.

There is considerable evidence that cADPR is required for a form of LTD in hippocampal neurons, although the exact mechanism by which cADPR exerts this effect is unclear. Both NMDAR-dependent and metabotropic-glutamate-receptor-dependent forms of LTD are found in the hippocampus of juvenile rats⁽Reference Nicoll, Oliet and Malenka¹²⁴⁾, and there is evidence for Ca release from ryanodine-sensitive stores in both. Early studies found that administration of dantrolene, a ryanodine channel blocker, blocked LTD and enhanced LTP in NMDAR-dependent hippocampal LTD⁽Reference O'Mara, Rowan and Anwyl¹²⁵⁾, while Ca influx through low-voltage-activated Ca channels and release of Ca from ryanodine-sensitive Ca stores was linked to a form of NMDAR-independent hippocampal LTD⁽Reference Wang, Rowan and Anwyl¹²⁶⁾. Later studies suggested that hippocampal LTD induction required release of Ca from both pre- and postsynaptic stores, with a ryanodine-sensitive channel as the presynaptic store and probably IP₃ as the postsynaptic store⁽Reference Reyes and Stanton¹²⁷⁾. Further investigation of the presynaptic role of RyR in hippocampal LTD determined that NMDAR-dependent LTD is followed by postsynaptic synthesis of NO and presynaptic activation of guanylyl cyclase, which probably enhances cADPR formation and the release of Ca from ryanodine-sensitive stores⁽Reference Reyes-Harde, Potter, Galione and Stanton^10, Reference Reyes-Harde, Empson, Potter, Galione and Stanton¹¹⁾. cADPR was finally shown experimentally to be associated with this presynaptic form of LTD in Reyes-Harde et al. ⁽Reference Reyes-Harde, Empson, Potter, Galione and Stanton¹¹⁾. Presynaptic modulation of LTD involves changes in neurotransmitter release, either through reductions in quantal size or frequency of transmission⁽Reference Nicoll, Oliet and Malenka¹²⁴⁾. It was recently shown that the NO/LTD cascade at the frog neuromuscular junction involves activation of calmodulin and the Ca-sensitive enzyme calcineurin⁽Reference Etherington and Everett¹²⁸⁾. The authors proposed that in this pathway, there is a long-lasting depression of transmitter release due to sustained activity of the NO signalling pathway following calcineurin-mediated dephosphorylation of NOS, which results in sustained NO production⁽Reference Etherington and Everett¹²⁸⁾. As previously discussed, both NMDAR-dependent and metabotropic-glutamate-receptor-dependent forms of LTD could involve modulation of the presynaptic neuron by a retrograde messenger, so these results are consistent with known LTD characteristics.

As just mentioned, release of Ca from ryanodine-sensitive stores was associated with depotentiation of previously established LTP in the rat dentate gyrus⁽Reference O'Mara, Rowan and Anwyl¹²⁵⁾. RyR have also been associated with the induction of the late form of LTP in the hippocampus in a process requiring NO, cGMP and cGMP protein-dependent kinase⁽Reference Lu, Kandel and Hawkins¹²⁹⁾. As cADPR synthesis is stimulated by cGMP⁽Reference Galione, White, Willmott, Turner, Potter and Watson⁵⁴⁾, it may also be involved in this cascade. RyR have been further implicated in weak LTP, as induced by a small conditioning stimulus, but not in the LTP that follows a moderate or strong conditioning protocol⁽Reference Raymond and Redman¹³⁰⁾. However, the evidence linking cADPR with LTP is not as clear as for LTD. In the only direct investigation of cADPR and LTP, administration of the cADPR antagonist 8-Br-cADPR had no effect on LTP induction⁽Reference Reyes-Harde, Empson, Potter, Galione and Stanton¹¹⁾ using an NMDAR-induction protocol. However, there are different types of LTP and several induction protocols that can be used, so this result is not conclusive. Investigations of type III RyR knockout mice, which might provide indirect evidence of the role of cADPR in LTP, have yielded conflicting results. In one study, RyR III knockout mice were found to exhibit decreased LTP in the CA1 region of the hippocampus and a decrease in α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor response, although this did not appear to be due to changes in receptor density⁽Reference Shimuta, Yoshikawa, Fukaya, Watanabe, Takeshima and Manabe¹³¹⁾. In a second study, RyR III knockout mice were found to exhibit facilitated LTP in the CA1 region of the hippocampus, with a corresponding impairment of LTD⁽Reference Futatsugi, Kato, Ogura, Li, Nagata, Kuwajima, Tanaka, Itohara and Mikoshiba¹³²⁾. And in a third study, RyR III knockout mice showed no change in CA1 LTP⁽Reference Balschun, Wolfer, Bertocchini, Barone, Conti, Zuschratter, Missiaen, Lipp, Frey and Sorrentino¹³³⁾. Each of these studies used different LTP induction protocols and experimental conditions, which shows that it is difficult to compare LTP results across studies when the same procedures are not used. Also, different strains of mice were used in these experiments, so there may have been differences between knockout models as well.

Due to the importance of the hippocampus in spatial learning⁽Reference Redish and Touretzky^12, Reference Morris, Garrud, Rawlins and O'Keefe¹³⁴⁾, altered hippocampal synaptic plasticity might be expected to affect this ability. Although there are no studies which directly link cADPR with spatial learning ability, two studies of the RyR III knockout mouse also looked at performance of these animals in the Morris water maze (MWM), which was introduced in 1981 as a tool to investigate spatial learning and memory in neurobehavioural research⁽Reference Morris¹³⁵⁾. As with LTP, these studies report different effects of RyR III gene deletion on behaviour. In Futatsugi et al. ⁽Reference Futatsugi, Kato, Ogura, Li, Nagata, Kuwajima, Tanaka, Itohara and Mikoshiba¹³²⁾, knockout mice showed improved spatial learning ability as evidenced by greater spatial accuracy in a probe trial, while in Balschun et al. ⁽Reference Balschun, Wolfer, Bertocchini, Barone, Conti, Zuschratter, Missiaen, Lipp, Frey and Sorrentino¹³³⁾, loss of RyR III had a negative effect on spatial learning ability, with animals showing reduced flexibility in relearning a new platform location. Although these results are not consistent, the studies also found that hippocampal neurons had different electrophysiological properties. The effect of RyR and cADPR on spatial learning ability is not clear at this time, although it has been shown that spatial learning increases the expression of RyR type II in the rat hippocampus⁽Reference Zhao, Meiri, Xu, Cavallaro, Quattrone, Zhang and Alkon¹³⁶⁾.

Dietary niacin, brain cyclic adenosine diphosphate ribose and spatial learning

We investigated the effect of dietary niacin on brain cADPR and MWM performance using three different models of niacin deficiency and one model of niacin supplementation⁽Reference Young, Jacobson and Kirkland¹³⁷⁾. In each, male weanling Long–Evans rats were used since performance of female rats in the water maze has also been show to vary across the oestrous cycle⁽Reference Warren and Juraska¹³⁸⁾ and tryptophan metabolism in females has been observed to change with hormonal variations⁽Reference Shibata and Kondo¹³⁹⁾. Long–Evans rats are the most commonly used rats in water maze experiments, and their ability to perform successfully has been well validated⁽Reference D'Hooge and De Deyn¹⁴⁰⁾. Although the use of weanling rats introduces some concerns about potential dietary effects on synaptogenesis and myelination, which are not complete until 60 d after birth⁽Reference Akiyama, Ichinose, Omori, Sakurai and Asou¹⁴¹⁾, we have previously shown that young rats show a much greater sensitivity to niacin deficiency than older rats, possibly due to a reduced tryptophan →  NAD⁺ conversion ability (JB Kirkland, unpublished results). The diets used in these experiments are modelled after AIN-93G (designed by the American Institute of Nutrition, formulated to meet gestation, lactation and growth requirements)⁽Reference Reeves, Nielsen and Fahey¹⁴²⁾, with 20 % casein replaced by 7 % casein and 6 % gelatin (Table 3⁾. This represents a low level of protein, and tryptophan content is limiting in order to minimise tryptophan →  NAD⁺ conversion. The micronutrient levels are as described for AIN-93G, with the exception of niacin content in deficient and high-dose diets. Nicotinamide was chosen as the supplemented form of niacin because the brain shows a preference for using nicotinamide in the synthesis of NAD⁺ over any other precursors, and there is an active mechanism for nicotinamide uptake into the brain, where it is distributed evenly⁽Reference Spector¹⁴³⁾. Pharmacological nicotinamide supplementation has been investigated as a treatment for type 1 diabetes in children, so the level of nicotinamide used was comparable with the human consumption of 1–3 g nicotinamide per d in the diabetes prevention trials⁽Reference Pozzilli, Browne and Kolb¹⁴⁴⁾.

Table 3

Composition of experimental diets (g/kg diet)

* Vitamin mix composition: sucrose, 97 543 mg/kg; vitamin B₁₂, 1 mg/kg; vitamin E (dl-α-tocopheryl acetate), 20 000 mg/kg; biotin, 20 mg/kg; calcium pantothenate, 1600 mg/kg; folic acid, 200 mg/kg; vitamin K (phylloquinone), 50 mg/kg; pyridoxine HCl, 700 mg/kg; riboflavin, 600 mg/kg; thiamin HCl, 600 mg/kg; retinyl palmitate, 800 mg/kg; cholecalciferol, 2·5 mg/kg.

For all of our experiments, statistical analyses were performed using SPSS (version 12.0 for Windows; SPSS Inc., Chicago, IL, USA). The P value was set at ≤ 0·05. A trend was defined as a P value between 0·05 and 0·1. The Kolmogorov–Smirnov and Shapiro–Wilk tests were used to evaluate normality. As the water maze data in each experiment showed an abnormal distribution on at least one experimental day, non-parametric tests were used to assess water maze performance. The Friedman test was performed to determine the within-subjects effect, and the Kruskal–Wallis test was performed to determine the between-subjects effect. The within-subjects factor was time (test day) and the between-subjects factor was diet. For probe trial analysis, one-way ANOVA were run comparing the number of platform crossings at each of the four possible platform locations. Two-tailed independent t tests were used to compare mean swim speeds and brain nucleotides. Data were not transformed before analysis.

In the first niacin-deficiency model, niacin-deficient rats were compared with pair-fed controls (n 8). Control rats were pair fed a diet containing 30 mg added nicotinic acid per kg diet throughout the duration of the experiment. This level is considered adequate to fully meet the needs of rats, and is found in AIN-93 formulations and most commercial rat chows. In the water maze, niacin-deficient rats showed superior spatial learning ability during acquisition on day 2 (P = 0·01), day 3 (P = 0·05), day 5 (P = 0·007) and day 6 (P = 0·001) out of 7 d of testing, and tended to do so on day 4 (P = 0·1) (Fig. 3(a)⁾. There was also a trend (P = 0·09) for higher spatial accuracy in a probe test. Brain NAD⁺ was decreased by 42 % and brain cADPR by 36 % (Table 4⁾. The pair-feeding model was used to control for differences in feed intake between niacin-deficient and control rats, since a deficiency of niacin, like most micronutrients, causes anorexia⁽Reference Kirkland, Rawling, Rucker, Zempleni, Suttie and McCormick¹⁴⁵⁾. In our experiments, niacin-deficient weanling rats usually consume between 5 and 8 g food per d over periods of up to 5 weeks⁽Reference Young, Jacobson and Kirkland¹³⁷⁾. In contrast, food intake of healthy rats should increase during the growth period, and normal levels can be more than twice that consumed during niacin deficiency⁽Reference Ahmed, Bedi, Warren and Kamel¹⁴⁶⁾. Both niacin-deficient and pair-fed rats are consequently significantly deprived of food, particularly in the later experimental weeks, and show a significantly reduced body weight when compared with normative rat growth charts.

Fig. 3

(a) Cumulative error of niacin-deficient (–●–) and pair-fed (–○–) rats in the water maze. Rats were tested in three daily trials across 6 d with an inter-trial interval of 2 h. The results of the three daily trials were averaged to give a mean value for each day of testing. Values are means (n 8), with their standard errors represented by vertical bars. * Mean value was significantly different from that of the pair-fed rats (P ≤ 0·05). (b) Cumulative error of niacin-deficient (–●–; n 9) and partially feed-restricted (–○–; n 8) rats in the water maze. Rats were tested in three daily trials across 6 d with an inter-trial interval of 2 h. The results of the three daily trials were averaged to give a mean value for each day of testing. Values are means, with their standard errors represented by vertical bars. * Mean value was significantly different from that of the partially feed-restricted rats (P ≤ 0·05). (c) Cumulative error of niacin-deficient (–●–) and niacin-recovered (–○–) rats during reversal training in the water maze. Rats were tested in three daily trials across 4 d with an inter-trial interval of 2 h. The reversal training followed an initial acquisition phase in the water maze and 4 d of niacin refeeding. The results of the three daily trials were averaged to give a mean value for each day of testing. Values are means (n 9), with their standard errors represented by vertical bars. * Mean value was significantly different from that of the niacin-recovered rats (P ≤ 0·05). (d) Cumulative error of niacin-supplemented (–●–; n 18) and control (–○–; n 15) rats in the water maze. Rats were tested in three daily trials across 6 d with an inter-trial interval of 2 h. The results of the three daily trials were averaged to give a mean value for each day of testing. Values are means, with their standard errors represented by vertical bars. * Mean value was significantly different from that of the control rats (P ≤ 0·05). (e) Proximity averages to the platform during hidden platform testing by Cd38^− / −  (–●–) and wild-type (–○–) mice across 7 d of testing. Mice were tested in three daily trials across 6 d with an inter-trial interval of 2 h. The results of the three daily trials were averaged to give a mean value for each day of testing. Values are means (n 10), with their standard errors represented by vertical bars. * Mean value was significantly different from that of the wild-type rats (P ≤ 0·05). Fig. 3(a–d) were originally published in Young et al. (2007)⁽Reference Young, Jacobson and Kirkland¹³⁷⁾. Fig. 3(e) was originally published in Young et al. (2008)⁽Reference Young, Choleris, Lund and Kirkland¹⁴⁹⁾.

Table 4

Brain NAD⁺ and cyclic adenosine diphosphate ribose (cADPR) in rats with differing niacin intakes and in Cd38^−/− mice (nmol/g tissue) (Mean values with their standard errors)

* Mean value was significantly different from that of rats in the comparative group (P ≤ 0·05).

In the second niacin-deficiency model, niacin-deficient rats were compared with partially feed-restricted controls (nine niacin-deficient rats and eight partially feed-restricted rats). Control rats were pair fed for the first 16 d of the experiment, and then fed ad libitum for 4 d before and during the entire period of water maze testing. In the water maze, we observed that niacin-deficient rats again showed superior performance on day 3 and day 4 (P < 0·05) of 6 d of testing, and tended to do so on day 6 (P = 0·08) (Fig. 3(b)⁾, although the spatial accuracy of the two groups was comparable in a probe test. Brain NAD⁺ and cADPR were not measured. The food intake and body weight of the two groups diverged greatly once the control group was placed on ad libitum feeding. The goal of this feeding strategy was to reduce hunger during the period of behavioural testing, while minimising the developmental differences that would result between niacin-deficient rats and rats fed ad libitum throughout the entire experiment.

In the third niacin-deficiency model, currently niacin-deficient rats were compared with niacin-recovered rats (n 9). All rats were maintained on a niacin-deficient diet during the first phase of water maze testing, and then half were recovered from the deficiency through niacin refeeding during the second phase of water maze testing. Nicotinamide was used since it is the preferred substrate for NAD⁺ in most tissues, including the brain⁽Reference Jacobson, Dame, Pyrek and Jacobson¹⁴⁷⁾ and should therefore allow for a more rapid replenishment of niacin metabolites. The 4 d period of niacin refeeding before the second phase of water maze testing was designed to mimic the period of nutritional rehabilitation typically required for resolution of the symptoms of pellagrous dementia⁽Reference Kirkland, Rawling, Rucker, Zempleni, Suttie and McCormick¹⁴⁵⁾. During the first phase of water maze testing, when all rats were niacin deficient, a retrospective analysis of performance revealed no significant differences between the two groups. However, during the second phase of water maze testing, when the recovered rats were being refed niacin, there was a significant effect of diet on day 4 (P = 0·01) and a trend on day 2 (P = 0·09) (Fig. 3(c)⁾, with comparable spatial accuracy in the probe test. It is important to note that during the second phase of testing, rats were no longer naive and had already undergone extensive water maze training, so the sensitivity of the test to detect subtle differences in spatial learning ability would be reduced. Brain NAD⁺ was decreased by 43 % and brain cADPR by 25 % (Table 4⁾. This approach sought to determine the flexibility of learning and brain cADPR to niacin refeeding.

In the niacin-supplementation model, niacin-supplemented rats were compared with control rats (eighteen supplemented rats and fifteen control rats). Niacin-supplemented rats were fed a diet containing 4 g added nicotinamide/kg diet. The amount of food eaten daily during this period by each rat was determined and was correlated to body weight, allowing for an estimation of the average amount of food eaten daily per g body weight. The amount was initially determined at 0·15 g food/g body weight, and this value was used to calculate the amount of food provided on each day of the experimental period. This level of food provision was used throughout the experiment, as the daily residual food suggested that it allowed ad libitum, or nearly ad libitum, feeding to all animals. In the water maze, supplemented rats showed inferior spatial learning ability on day 3 (P = 0·04) of 6 d of testing (Fig. 3(d)⁾. Brain NAD⁺ was increased by 38 % and brain cADPR by 14 % (Table 4⁾.

The consistency of the finding of improved spatial learning ability in each niacin-deficiency model is striking. This, combined with the opposite observation following nicotinamide supplementation, is supportive of an inverse relationship between spatial learning ability and dietary niacin intake in very young rats. Although the link between dietary niacin, spatial learning ability and cADPR is correlational, dietary niacin might affect brain function through cADPR modulation. Like niacin, brain cADPR shows an inverse relationship with spatial learning ability, and while cADPR levels are quickly restored to normal following niacin refeeding, the cognitive benefits associated with the deficiency rapidly disappear.

CD38, brain cyclic adenosine diphosphate ribose and spatial learning

We also investigated the effect of CD38 gene deletion on brain cADPR⁽Reference Young, Choleris, Lund and Kirkland¹⁴⁸⁾ and MWM performance⁽Reference Young, Choleris, Lund and Kirkland¹⁴⁹⁾. The Cd38^− / −  mouse was originally generated to study the role of CD38 in humoral immunity, and has subsequently been used in investigations of airway smooth muscle function⁽Reference Deshpande, White, Guedes, Milla, Walseth, Lund and Kannan¹⁵⁰⁾, glucose tolerance⁽Reference Kato, Yamamoto, Fujimura, Noguchi, Takasawa and Okamoto¹⁵¹⁾, osteogenesis⁽Reference Sun, Iqbal and Dolgilevich¹⁵²⁾ and innate immunity⁽Reference Partida-Sánchez, Cockayne and Monard^56, Reference Partida-Sanchez, Randall and Lund¹⁵³⁾. While the original study of the Cd38^− / −  mouse reported comparable behaviour between knockout and wild-type animals⁽Reference Cockayne, Muchamuel, Grimaldi, Muller-Steffner, Randall, Lund, Murray, Schuber and Howard¹⁵⁴⁾, there have been no comprehensive investigations of specific behavioural functions in this transgenic model. Cd38^− / −  mice were generated by gene targeting⁽Reference Cockayne, Muchamuel, Grimaldi, Muller-Steffner, Randall, Lund, Murray, Schuber and Howard¹⁵⁴⁾ and were backcrossed for twelve generations to C57BL/6J⁽Reference Partida-Sánchez, Cockayne and Monard⁵⁶⁾. This practice complies with the recommendation of the Banbury Conference that targeted mutations be maintained in congenic lines⁽¹⁵⁵⁾, although it is nonetheless likely that the knockouts carry alleles for genes that flank the mutation locus⁽Reference Crusio¹⁵⁶⁾. Backcrossing for twelve generations would reduce the length of the chromosome segment from the background genotype to about 16 cM, which when considered in relation to the mouse genome, would contain approximately 300 genes⁽Reference Gerlai¹⁵⁷⁾. So, the Cd38^− / −  mouse would contain more than 99 % C57BL/6J genes. When inbred mouse strains are evaluated in the MWM, C57BL/6 mice are often characterised as being the strain of choice, and their ability to learn the task has been validated experimentally⁽Reference Crawley, Belknap and Collins¹⁵⁸⁾.

We observed that brain cADPR was increased (P < 0·001) in the Cd38^− / −  mouse as compared with wild-type controls (n 15)⁽Reference Young, Choleris, Lund and Kirkland¹⁴⁸⁾ (Table 4⁾. This is in contrast to Partida-Sánchez et al. ⁽Reference Partida-Sánchez, Cockayne and Monard⁵⁶⁾ and Ceni et al. ⁽Reference Ceni, Pochon, Villaz, Muller-Steffner, Schuber, Baratier, De Waard, Ronjat and Moutin¹⁰³⁾, who previously measured levels of cADPR in these tissues and found them to be non-significantly decreased. While our levels of brain cADPR are comparable with other published reports, the degree of variability in each group is reduced, which we believe is due to modifications that we have made to the fluorimetric cycling assay for cADPR. These modifications are shown to increase the recovery of cADPR, improve the functionality of the assay, and reduce between-subject variability⁽Reference Young and Kirkland¹⁵⁹⁾. In fact, we observed a significant reduction of brain cADPR despite a difference of only 16% between wild-type and knockout mice, in contrast to the 20% non-significant reduction observed by Partida-Sanchez et al. ⁽Reference Partida-Sánchez, Cockayne and Monard⁵⁶⁾ and the 18% non-significant reduction observed in Ceni et al. ⁽Reference Ceni, Pochon, Villaz, Muller-Steffner, Schuber, Baratier, De Waard, Ronjat and Moutin¹⁰³⁾. We also observed that levels of NAD⁺ in the brain were increased by 160%⁽Reference Young, Choleris, Lund and Kirkland¹⁴⁸⁾ (P < 0·001) (Table 4⁾. CD38 is a multifunctional enzyme that functions as both a cyclase and a hydrolase enzyme, forming ADP-ribose from hydrolysis of NAD⁺ or cADPR. Since the ratio of cyclase:hydrolase activity is low⁽Reference Schuber and Lund¹⁶⁰⁾, the loss of NAD⁺ hydrolase activity might explain an increase in NAD⁺ of this magnitude, and the differential activity of this enzyme would result in a much greater effect on NAD⁺ increase than on cADPR reduction, which is what we observed.

We also observed that like niacin-deficient rats, Cd38^− / −  mice show improved performance in the MWM as compared with wild-type controls (n 10). Cd38^− / −  mice had a significantly shorter latency to the hidden platform on day 5 (P = 0·05) of 7 d of testing, and there was a trend for a shorter latency on day 7 (P = 0·1). Analysis of the proximity average, which takes into account how close the animal comes to the platform⁽Reference Gallagher, Burwell and Burchinal¹⁶¹⁾, confirmed that on day 5 Cd38^− / −  mice performed significantly better than wild-type mice (P = 0·001), while on day 7, there was a trend (P = 0·07) for better performance by the Cd38^− / −  mice (Fig. 3(e)⁾. The mean proximity averages were lower for Cd38^− / −  mice from day 4 to day 7, demonstrating a consistent pattern for Cd38^− / −  mice to perform better than wild-type mice in the water maze on these days. In the probe trial, there was a trend (P = 0·07) for Cd38^− / −  mice to cross the target location more times than wild-type mice. Although the effect of CD38 gene deletion on water maze performance was less than seen in niacin deficiency, the results are nonetheless consistent with our previous observation of reduced brain cADPR and improved spatial learning ability in niacin-deficient rats. The magnitude of cADPR change was greater in the niacin-deficiency models than in Cd38^− / −  mice (25–35 v. 16 %), so when considered relative to this, these results suggest that although CD38 forms only a proportion of brain cADPR, its removal impacts on brain function by a similar mechanism as that of niacin deficiency. Unlike niacin-deficient rats, which have reduced brain NAD⁺⁽Reference Young, Jacobson and Kirkland¹³⁷⁾, the spatial learning effect in Cd38^− / −  mice is observed with increased brain NAD⁺.

This was a revealing observation, as it identified total cADPr, and/or CD38-catalytic activity (capable of cADPr or NAADP synthesis), as parameters that correlated with MWM performance across all models (niacin-deficient/control/pharmacological nicotinic acid diets in rats, Cd38^− / −  v. wild-type mice). Conversely, brain NAD⁺, and, by extension, the assumed activity of all other NAD⁺-dependent enzymes did not correlate with performance across all models.